Pharma Leaders

MAY 12, 2023

It makes sense of everything successful drug and device manufacturers must know and do, delivering the news, analysis and interpretation of industry changes you need to stay in compliance and thrive.

Drug Development 52

Drug Development Documentation 52

Viseven

AUGUST 7, 2024

As most documents come in a PDF format, Adobe Acrobat is helpful for this task. As stated by Cynthia Kryder in the book ‘The Accidental Medical Writer,’ you have to spend money to make money. Essential resources include a nursing procedure book, physician desk reference, and medical dictionary.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 6, 2022

Iddo Peleg (CEO, and one of the four co-founders of YonaLink) and Gav Martell (co-founder and vice president of business development) discussed how a recent $6 million funding round led by Debiopharm Innovation Fund will support their mission to transform clinical trials and bring lifesaving therapies to market faster.

Data Entry 98

Data Entry Communication Hospitals Documentation 98

Putting Patients First Blog

FEBRUARY 6, 2024

The price of progress: funding and financing Alzheimer’s disease drug development. autm.net/AUTMMain/media/Partner-Events/Documents/Economic-_Contribution_University- Nonprofit_Inventions_US_1996-2015_BIO_AUTM.pdf 16 Lanahan, L., bi.nlm.nih.gov/books/NBK196184/ 24 National Health Council. Nature Communications, 11(6265).

Communication 40

Communication Documentation Drug Development 40

pharmaphorum

JANUARY 18, 2022

Smart device developers. Training device developers. Drug developers. BOOK BY 17 th DECEMBER AND SAVE $400. BOOK BY 31 st JANUARY AND SAVE $200. BOOK BY 28 TH FEBRUARY AND SAVE $100. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

European Pharmaceutical Review

JANUARY 16, 2023

“Clearly the number one challenge in 2022, as mandated by the EU GMP Guidelines for the Manufacture of Sterile Medicinal Products Annex 1 1 , is the development of a Contamination Control Strategy (CCS),” Tony Cundell noted. He warned, “Implementation of a CCS will require more than writing documents.”. About the authors.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

FDA Law Blog: Biosimilars

DECEMBER 6, 2024

As much of the content of this draft guidance for cellular and gene therapy (CGT) products is articulated elsewhere, this document serves as a one-stop shop or Cliffs Notes for the numerous guidance documents now covering CGT product development.

Documentation 59

Documentation Packaging Clinical Pharmacology Drug Development 59